Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short vs Protracted Neoadjuvant Hormonal Therapy in Prostate Cancer
NCT00003734Phase 3Unknown
- Sponsor
- St. Luke's Hospital
- Start
- Dec 1998
- Modality
- Peptides, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of triptorelin, flutamide in prostate cancer (PCa), sponsored by St. Luke's Hospital. Status: unknown.
02
Drugs
triptorelinflutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00003734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003734.